Since the discovery of BRCA1 and BRCA2 as breast cancer susceptibility genes (Miki et al, 1994; Wooster et al, 1994), much focus has been placed on discovering additional DNA variants that are associated with FBC development. This evidence concerns the gene BRCA2 and breast carcinoma.